The Road to Mass Spec Imaging in Clinical Research
Moving MALDI MSI-based tissue typing from the lab into clinical research pathology
Alice Ly | | Longer Read
At a Glance
- Mass spectrometry imaging could be valuable in the clinic – if existing concerns can be addressed
- MSI allows measurement of small-sized samples and good specimen preservation for additional studies
- It can also be combined with other techniques, such as digital PCR, to make best use of limited biopsy tissue
- Although MSI shows promise for clinical use, standardization efforts are needed, because results remain variable
Until relatively recently, matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) was restricted to basic science – and it has yet to be widely accepted for clinical research analysis. For MSI to migrate from a research platform to a universally accepted tool, it requires a standardized procedure for everyone using the technique and concerns regarding reproducibility must be addressed. Pathology laboratories increasingly rely on molecular testing that uses genomic technology; emerging molecular technologies, such as MSI, that provide dynamic, untargeted information about the cell’s active state are likely to follow suit in the coming years.
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.